Formula & Concentration

BRIVIACT (brivaracetam)* tablets, for oral use, CV

BRIVIACT (brivaracetam)* oral solution, CV

BRIVIACT (brivaracetam)* injection, for intravenous use, CV

Manufacturer

UCB

Indications

  • BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.

Product Options

Package Size

NDC #

Presentation

10mg -60 tablets

50474-0370-66

60 Tablets

25mg -60 tablets

50474-0470-66

60 Tablets

50mg-60 tablets

50474-0570-66

60 Tablets

75mg-60 tablets

50474-0670-66

60 Tablets

100mg-60 tablets

50474-0770-66

60 Tablets

25mg -unit dose carton of 100 tablets

50474-0470-09

unit dose carton of 100 tablets

50mg -unit dose carton of 100 tablets

50474-0570-09

unit dose carton of 100 tablets

100mg -unit dose carton of 100 tablets

50474-0770-09

unit dose carton of 100 tablets

10mg/mL oral solution

50474-0870-15

Oral solution (300ml)

50 mg/5 mL injection for intravenous use

50474-0970-75

10 vials

Shelf Life and Storage

  • Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). See USP Controlled Room Temperature.
  • Do not freeze BRIVIACT injection or oral solution.
  • Discard any unused BRIVIACT oral solution remaining after 5 months of first opening the bottle.
  • BRIVIACT injection vials are single-dose only

*BRIVIACT contains brivaracetam and is listed as a Schedule V controlled substance.